Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

COYA

COYA News

Newswire

08:33

Coya Therapeutics: Chardan Capital maintains Buy rating, raises PT to $14 from $14.

13:31

Coya Therapeutics: BTIG raises Buy rating, PT increased to $16 from $15.

14:16

Coya Therapeutics: Buy Rating Maintained, PT Raised to $15

08:09

Coya Therapeutics Q3 Revenue Down 12% YoY, FDA Accepts ALS Treatment IND.

09:22

Coya Therapeutics shares jump 10.83% premarket as COYA 303 shows potent anti-inflammatory efficacy in animal study.

View More

About COYA

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More